Benefit of carbamazepine in a patient with hemiplegic migraine associated with PRRT2 mutation

Developmental Medicine and Child Neurology

Volumn 56, Issue 9, 2014, Pages 910-910

  Dale, Russell C ^a   Gardiner, Alice ^b   Branson, Joceline A ^c   Houlden, Henry ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; PROTEIN; PRRT2 PROTEIN; UNCLASSIFIED DRUG;

CASE REPORT; CHILD; CHOREOATHETOSIS; EPILEPSY; EXERCISE; GENE MUTATION; HEMIPLEGIC MIGRAINE; HUMAN; INFANTILE SPASM; LETTER; MALE; NEUROLOGIC DISEASE; PARESTHESIA; PAROXYSMAL KINESIGENIC DYSKINESIA; PATIENT COMPLIANCE; PRIORITY JOURNAL; SCHOOL CHILD;

ANALGESICS, NON-NARCOTIC; CARBAMAZEPINE; CHILD; FAMILY; HUMANS; MALE; MEMBRANE PROTEINS; MIGRAINE WITH AURA; MUTATION; NERVE TISSUE PROTEINS;

EID: 84905753715     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/dmcn.12396     Document Type: Letter

References (6)

1. Chen WJ, Lin Y, Xiong ZQ, et al. Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia. Nat Genet 2011; 43: 1252-5.
2. Heron SE, Grinton BE, Kivity S, et al. PRRT2 mutations cause benign familial infantile epilepsy and infantile convulsions with choreoathetosis syndrome. Am J Hum Genet 2012; 90: 152-60.
3. Gardiner AR, Bhatia KP, Stamelou M, et al. PRRT2 gene mutations: from paroxysmal dyskinesia to episodic ataxia and hemiplegic migraine. Neurology 2012; 79: 2115-21.
4. Riant F, Roze E, Barbance C, et al. PRRT2 mutations cause hemiplegic migraine. Neurology 2012; 79: 2122-4.
5. Dale RC, Gardiner A, Antony J, Houlden H. Familial PRRT2 mutation with heterogeneous paroxysmal disorders including paroxysmal torticollis and hemiplegic migraine. Dev Med Child Neurol 2012; 54: 958-60.
6. Linde M, Mulleners WM, Chronicle EP, McCrory DC. Antiepileptics other than gabapentin, pregabalin, topiramate, and valproate for the prophylaxis of episodic migraine in adults. Cochrane Database Syst Rev 2013; 6: CD010608.